Compile Data Set for Download or QSAR
Report error Found 659 Enz. Inhib. hit(s) with Target = 'Tyrosine-protein kinase TXK'
TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM458182(US10752615, Compound 75)
Affinity DataIC50: 0.120nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM209866(PF-06651600 | US9617258, Example 5 | US11111242, E...)
Affinity DataKi:  0.131nMpH: 7.5Assay Description:Assay buffer was 20 mM HEPES, pH 7.5, 10 mM MgCl2, 0.01% BSA, 1 mM DTT, 0.0005% Tween 20, and 2% DMSO. Inactivation kinetic reactions were performed ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2017
Entry Details Article
PubMed
TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM50458600(CHEMBL4206765 | US10752615, Compound 97)
Affinity DataIC50: 0.140nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM50458600(CHEMBL4206765 | US10752615, Compound 97)
Affinity DataIC50: 0.140nMAssay Description:Inhibition of TXK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details Article
PubMed
TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM50458604(CHEMBL4214683 | US10752615, Compound 149)
Affinity DataIC50: 0.140nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM50458604(CHEMBL4214683 | US10752615, Compound 149)
Affinity DataIC50: 0.140nMAssay Description:Inhibition of TXK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details Article
PubMed
TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM50458601(CHEMBL4217959 | US10752615, Compound 138)
Affinity DataIC50: 0.160nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM458238(US10752615, Compound 136)
Affinity DataIC50: 0.160nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM50458601(CHEMBL4217959 | US10752615, Compound 138)
Affinity DataIC50: 0.160nMAssay Description:Inhibition of TXK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details Article
PubMed
TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM50458588(CHEMBL4219011 | US10752615, Compound 131)
Affinity DataIC50: 0.180nMAssay Description:Inhibition of TXK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details Article
PubMed
TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM458213(US10752615, Compound 110)
Affinity DataIC50: 0.180nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM50458597(CHEMBL4203077 | US10752615, Compound 4)
Affinity DataIC50: 0.180nMAssay Description:Inhibition of TXK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details Article
PubMed
TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM50458588(CHEMBL4219011 | US10752615, Compound 131)
Affinity DataIC50: 0.180nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM50458597(CHEMBL4203077 | US10752615, Compound 4)
Affinity DataIC50: 0.180nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM458247(US10752615, Compound 145)
Affinity DataIC50: 0.200nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM50458587(CHEMBL4207292)
Affinity DataIC50: 0.200nMAssay Description:Inhibition of TXK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details Article
PubMed
TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM458230(US10752615, Compound 128)
Affinity DataIC50: 0.200nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM458242(US10752615, Compound 140)
Affinity DataIC50: 0.200nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM384539(N-(1-(((R)-1-acryloylpyrrolidin-2-yl)methyl)-5-(((...)
Affinity DataIC50: 0.200nMAssay Description:The ability of the compounds of the present disclosure to inhibit ITK was measured using the Caliper assay format, which is an electrophoretic separa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2020
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM458119(US10752615, Compound 9)
Affinity DataIC50: 0.200nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM458231(US10752615, Compound 129)
Affinity DataIC50: 0.210nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM50458592(CHEMBL4211372 | US10752615, Compound 16)
Affinity DataIC50: 0.210nMAssay Description:Inhibition of TXK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details Article
PubMed
TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM50458592(CHEMBL4211372 | US10752615, Compound 16)
Affinity DataIC50: 0.210nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM458249(US10752615, Compound 147)
Affinity DataIC50: 0.210nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM458248(US10752615, Compound 146)
Affinity DataIC50: 0.220nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM458216(US10752615, Compound 114)
Affinity DataIC50: 0.220nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM50458589(CHEMBL4208358 | US10752615, Compound 57)
Affinity DataIC50: 0.220nMAssay Description:Inhibition of TXK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details Article
PubMed
TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM50458589(CHEMBL4208358 | US10752615, Compound 57)
Affinity DataIC50: 0.220nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM458227(US10752615, Compound 125)
Affinity DataIC50: 0.240nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM458258(US10752615, Compound 156)
Affinity DataIC50: 0.240nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM50458596(CHEMBL4216187 | US10752615, Compound 50)
Affinity DataIC50: 0.25nMAssay Description:Inhibition of TXK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details Article
PubMed
TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM50458596(CHEMBL4216187 | US10752615, Compound 50)
Affinity DataIC50: 0.25nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM458180(US10752615, Compound 73)
Affinity DataIC50: 0.260nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM458164(US10752615, Compound 56)
Affinity DataIC50: 0.260nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM458137(US10752615, Compound 29)
Affinity DataIC50: 0.270nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM458222(US10752615, Compound 120)
Affinity DataIC50: 0.280nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM50458593(CHEMBL4204572 | US10752615, Compound 30)
Affinity DataIC50: 0.290nMAssay Description:Inhibition of TXK (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details Article
PubMed
TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM458243(US10752615, Compound 141)
Affinity DataIC50: 0.290nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM50458593(CHEMBL4204572 | US10752615, Compound 30)
Affinity DataIC50: 0.290nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM458166(US10752615, Compound 58)
Affinity DataIC50: 0.290nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM384541(N-(1-(((R)-1-acryloylpyrrolidin-2-yl)methyl)-5-(((...)
Affinity DataIC50: 0.300nMAssay Description:The ability of the compounds of the present disclosure to inhibit ITK was measured using the Caliper assay format, which is an electrophoretic separa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2020
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM384543((R)-N-(1-((1-acryloylpyrrolidin-2-yl)methyl)-5-(((...)
Affinity DataIC50: 0.300nMAssay Description:The ability of the compounds of the present disclosure to inhibit ITK was measured using the Caliper assay format, which is an electrophoretic separa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2020
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM458162(US10752615, Compound 54)
Affinity DataIC50: 0.300nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM384542(N-(1-(((R)-1-acryloylpyrrolidin-2-yl)methyl)-5-(((...)
Affinity DataIC50: 0.300nMAssay Description:The ability of the compounds of the present disclosure to inhibit ITK was measured using the Caliper assay format, which is an electrophoretic separa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2020
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM13216(N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyeth...)
Affinity DataIC50: 0.300nMAssay Description:Inhibition of TXKMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2011
Entry Details Article
PubMed
TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM384538((R)-N-(1-((1-acryloylpyrrolidin-2-yl)methyl)-5-(((...)
Affinity DataIC50: 0.300nMAssay Description:The ability of the compounds of the present disclosure to inhibit ITK was measured using the Caliper assay format, which is an electrophoretic separa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2020
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM458202(US10752615, Compound 98)
Affinity DataIC50: 0.310nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM458151(US10752615, Compound 43)
Affinity DataIC50: 0.320nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM50458603(CHEMBL4216529 | US10752615, Compound 42)
Affinity DataIC50: 0.320nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetTyrosine-protein kinase TXK(Human)
Gb005

US Patent
LigandPNGBDBM458141(US10752615, Compound 33)
Affinity DataIC50: 0.320nMAssay Description:The in vitro kinase assays were performed at Nanosyn (Santa Clara, Calif.) utilizing microfluidic detection technology. The test compounds were seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

Displayed 1 to 50 (of 659 total ) | Next | Last >>
Jump to: